Orizon T
-
DATABASE (2907)
-
ARTICLES (122)
Based in London, CPT Capital is the venture arm of private equity pioneer Jeremy Coller's private family office. Coller is the founder of Europe’s first private equity for secondaries in 1990. The British philanthropist has also established several business schools and the Jeremy Coller Foundation that aims to eliminate factory farming. In 2017, CPT Capital was founded to disrupt the food industry with investments in the alt-protein sector to create the “future of food and materials” like plant-based, recombinant and cell-cultured proteins.
Based in London, CPT Capital is the venture arm of private equity pioneer Jeremy Coller's private family office. Coller is the founder of Europe’s first private equity for secondaries in 1990. The British philanthropist has also established several business schools and the Jeremy Coller Foundation that aims to eliminate factory farming. In 2017, CPT Capital was founded to disrupt the food industry with investments in the alt-protein sector to create the “future of food and materials” like plant-based, recombinant and cell-cultured proteins.
Founded in 2016 by Gary Schefsky, New Luna Ventures focuses on sustainable investments in diverse sectors including agriculture, food tech, precision farming, materials, real estate, renewables, water technology, communications, SaaS, AI and robotics. Schefsky has worked in emerging startup sectors for over 25 years and as a family office fiduciary for more than 17 years. Based in San Francisco, the firm’s limited partners include family offices, institutional investors and individuals.
Founded in 2016 by Gary Schefsky, New Luna Ventures focuses on sustainable investments in diverse sectors including agriculture, food tech, precision farming, materials, real estate, renewables, water technology, communications, SaaS, AI and robotics. Schefsky has worked in emerging startup sectors for over 25 years and as a family office fiduciary for more than 17 years. Based in San Francisco, the firm’s limited partners include family offices, institutional investors and individuals.
Founded in September 2019 by Patrick Morris, Eat Beyond went public on the Canadian Securities Exchange in November 2020. The company’s shares are also traded on the Frankfurt Exchange in Germany and OTC Markets in the US. Morris had worked in capital markets for over 15 years and wanted to find a solution to help retail investors access the emerging markets of alt-proteins and other future food sectors.First of its kind in Canada, the Eat Beyond Global Investment Fund focuses on four key areas: meat, seafood, eggs, and dairy. It also participates in cell agriculture and other experimental projects. Current investments include foodtechs and alt-food source companies working on plant-based proteins, fermented proteins, cultured proteins, agriculture and consumer packaged goods.
Founded in September 2019 by Patrick Morris, Eat Beyond went public on the Canadian Securities Exchange in November 2020. The company’s shares are also traded on the Frankfurt Exchange in Germany and OTC Markets in the US. Morris had worked in capital markets for over 15 years and wanted to find a solution to help retail investors access the emerging markets of alt-proteins and other future food sectors.First of its kind in Canada, the Eat Beyond Global Investment Fund focuses on four key areas: meat, seafood, eggs, and dairy. It also participates in cell agriculture and other experimental projects. Current investments include foodtechs and alt-food source companies working on plant-based proteins, fermented proteins, cultured proteins, agriculture and consumer packaged goods.
Established in 1958, VERSO Capital is a boutique merchant banking and financial services firm based in Luxembourg. It also has offices in Geneva, Fribourg, Vaduz, Dubai, Singapore and BVI. VERSO specializes in sectors like education, food and renewables. Since 2011, the firm has invested over $700bn in venture capital in the global startup ecosystem. Funds worth over $245m were pumped into climatech, foodtech and biotech sectors since 2017. In February 2021, it merged with Swiss alternative asset manager ALDINI Capital that was also founded in 1958 and based in Switzerland and Liechtenstein. VERSO will leverage the expertise of ALDINI in hedge funds, private equity and real estate.
Established in 1958, VERSO Capital is a boutique merchant banking and financial services firm based in Luxembourg. It also has offices in Geneva, Fribourg, Vaduz, Dubai, Singapore and BVI. VERSO specializes in sectors like education, food and renewables. Since 2011, the firm has invested over $700bn in venture capital in the global startup ecosystem. Funds worth over $245m were pumped into climatech, foodtech and biotech sectors since 2017. In February 2021, it merged with Swiss alternative asset manager ALDINI Capital that was also founded in 1958 and based in Switzerland and Liechtenstein. VERSO will leverage the expertise of ALDINI in hedge funds, private equity and real estate.
Rick Klausner is an award-winning scientist, former executive director of the Bill & Melinda Gates Foundation and an entrepreneur. Cell and molecular biologist Klausner was also director of the US National Cancer Institute from 1999-2001 and currently serves as CEO at biotech Lyell Immunopharma working with cell-based technology. He has also co-founded three US healthcare startups to date, Juno Therapeutics in 2013, MindStrong Health in 2014 and GRAIL in 2015. In 2021, he participated as an investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Rick Klausner is an award-winning scientist, former executive director of the Bill & Melinda Gates Foundation and an entrepreneur. Cell and molecular biologist Klausner was also director of the US National Cancer Institute from 1999-2001 and currently serves as CEO at biotech Lyell Immunopharma working with cell-based technology. He has also co-founded three US healthcare startups to date, Juno Therapeutics in 2013, MindStrong Health in 2014 and GRAIL in 2015. In 2021, he participated as an investor in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Founded in Silicon Valley by serial investor and founder of Google Ventures Bill Marris, Section 32 has multiple investment interests with medicine and biotech key amongst them. Marris himself has invested in over 500 companies, with over one-third resulting in IPO or M&A. Fifty of his portfolio companies have exceeded $1bn valuations, including Uber. Section 32 currently has 48 companies in its portfolio. Its most recent investments have included in Canadian remote medicine platform Cover Health’s $43m Series B round and in the $100m Series B round of US cancer detection software C2i Genomics, both in April 2021. In March 2021, it participated in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
Founded in Silicon Valley by serial investor and founder of Google Ventures Bill Marris, Section 32 has multiple investment interests with medicine and biotech key amongst them. Marris himself has invested in over 500 companies, with over one-third resulting in IPO or M&A. Fifty of his portfolio companies have exceeded $1bn valuations, including Uber. Section 32 currently has 48 companies in its portfolio. Its most recent investments have included in Canadian remote medicine platform Cover Health’s $43m Series B round and in the $100m Series B round of US cancer detection software C2i Genomics, both in April 2021. In March 2021, it participated in the $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
DSM Venturing is the investment arm of major Dutch biotech company DSM that has been investing in startups since 2006. The company currently has 36 startups in its portfolio across geographies and has managed three exits to date. It typically invests between €100,000 and €5m, with a lifetime investment varying from €1m–20m and usually requires board membership alongside investment. It has offices in the Netherlands and the US, both on the east and west coast. Its recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the same month, in the $8m Series A round of British anti-pollution biotech Deep Branch Biotechnology.
Founded in 2016, Berlin-based investor BlueYard invests in startups aiming to tackle the planet’s greatest challenges. It typically makes $1m–3m as an initial investment and has no geographical bias. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech and in the February 2021 $4m seed round of Next Matter, a German Open Source automation tool for operations teams.
Founded in 2016, Berlin-based investor BlueYard invests in startups aiming to tackle the planet’s greatest challenges. It typically makes $1m–3m as an initial investment and has no geographical bias. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech and in the February 2021 $4m seed round of Next Matter, a German Open Source automation tool for operations teams.
Founded in 2011, London-based Agronomics Limited’s principal investing interest is in environmentally-friendly alternatives to the traditional production of meat, wherever they may be located. There are currently 17 companies in its portfolio, all of them in the cellular-based or plant-based protein category and sustainable food production.Its most recent declared investments have been in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the December 2020 undisclosed pre-seed round of Chinese cellular foodtech CellX.
Founded in 2011, London-based Agronomics Limited’s principal investing interest is in environmentally-friendly alternatives to the traditional production of meat, wherever they may be located. There are currently 17 companies in its portfolio, all of them in the cellular-based or plant-based protein category and sustainable food production.Its most recent declared investments have been in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the December 2020 undisclosed pre-seed round of Chinese cellular foodtech CellX.
New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech.
New York-based Humboldt Fund invests in startups with the potential to solve critical issues of our time across the areas of food production, healthcare, energy, and construction and manufacturing materials. It currently has 14 companies in its portfolio. Its most recent investments include in the March 2021 $48m Series A round of Dutch cell-based meat startup Meatable which leverages pluripotent stem cells for the first time in foodtech, and in the February 2021 $16m seed round of US biotech Cellino Biotech.
Founded in Berlin in 2016, Atlantic Food Labs’ mission is to support startups with the potential to feed 10bn people by 2050. It has supported 20 companies to date and its most recent investments include in the German healthy last-minute delivery service Gorillas’ $290m Series B round and in the €5.9m seed round of B2B German retail connection service Magaloop in March 2021.
Founded in Berlin in 2016, Atlantic Food Labs’ mission is to support startups with the potential to feed 10bn people by 2050. It has supported 20 companies to date and its most recent investments include in the German healthy last-minute delivery service Gorillas’ $290m Series B round and in the €5.9m seed round of B2B German retail connection service Magaloop in March 2021.
BACKED VC is primarily a seed-stage funder based in London and founded in 2015 that selects its investments based on the founding team rather than on market-based decisions. It typically invests from €0.5m to €2.5m per round and, to date, has invested in 45 startups with two exits so far. Its most recent investments include in the March 2021 £5m Series A round of British legal digitization platform Legl and in the February 2021 £2.7m seed round of UK-based cellular fat producer Hoxton Farms.
BACKED VC is primarily a seed-stage funder based in London and founded in 2015 that selects its investments based on the founding team rather than on market-based decisions. It typically invests from €0.5m to €2.5m per round and, to date, has invested in 45 startups with two exits so far. Its most recent investments include in the March 2021 £5m Series A round of British legal digitization platform Legl and in the February 2021 £2.7m seed round of UK-based cellular fat producer Hoxton Farms.
Founded in 2016, Paris-based Future Positive Capital invests in European startups in deep tech and biotechnology to solve major problems, with funding for only 20 portfolio startups. It has backed eight startups to date with its most recent investments being in the April 2021 undisclosed €5.2m funding round of French renewable energytech SWEETCH Energy and in the £7.9m Series A round of British ecosystem restoration technology Dendra Systems in September 2020.
Founded in 2016, Paris-based Future Positive Capital invests in European startups in deep tech and biotechnology to solve major problems, with funding for only 20 portfolio startups. It has backed eight startups to date with its most recent investments being in the April 2021 undisclosed €5.2m funding round of French renewable energytech SWEETCH Energy and in the £7.9m Series A round of British ecosystem restoration technology Dendra Systems in September 2020.
Charles Songhurst is a founding partner of hedge fund Katana Capital and also runs the Songhurst Group, which holds assets in a variety of private companies, besides being a prolific angel investor having invested in more than 500 companies to date across sectors and geographies. His most recent investments have included in the 2021 seed rounds of home-based eye medtech Quadrant Eye and in the $2m funding of Canadian small business logistics startup Tyltgo. Songhurst is a former general manager and former head of corporate strategy at Microsoft. He has a bachelor's in philosophy, politics and economics from Oxford University.
Charles Songhurst is a founding partner of hedge fund Katana Capital and also runs the Songhurst Group, which holds assets in a variety of private companies, besides being a prolific angel investor having invested in more than 500 companies to date across sectors and geographies. His most recent investments have included in the 2021 seed rounds of home-based eye medtech Quadrant Eye and in the $2m funding of Canadian small business logistics startup Tyltgo. Songhurst is a former general manager and former head of corporate strategy at Microsoft. He has a bachelor's in philosophy, politics and economics from Oxford University.
Jörg Mohaupt is the head of media at Warner Music Group and an angel investor who has funded several startups to date, many in the area of music. His other most recently known investments were in the August 2019 £2.2m seed round of British fintech for adolescents Penfold and in the May 2019 $1.7m seed round of Swedish music sampling store Tracklib.
Jörg Mohaupt is the head of media at Warner Music Group and an angel investor who has funded several startups to date, many in the area of music. His other most recently known investments were in the August 2019 £2.2m seed round of British fintech for adolescents Penfold and in the May 2019 $1.7m seed round of Swedish music sampling store Tracklib.
Nutrinsect: Aiming at insects for human consumption for the planet's sake
Nutrinsect expects insect-based foodstuffs to supplement meat to satisfy the ever-growing hunger for protein
Day Day Cook: Creating content that sells
She may not be a celebrity chef but Norma Chu, the analyst-turned-cook, is a familiar face in food-obsessed Hong Kong, where she has her recipe website to encourage youths to learn cooking
TOPDOX relaunched: from consumer to corporate
Half a million users later, productivity software startup TOPDOX made the jump to B2B. Its co-founder and CEO, Nelson Pereira, tells us why
Alpha JWC Ventures bets on Indonesian fintech, analytics startups for big impact
A commitment to mentoring and supporting its portfolio companies also lies at the core of its business
Faromatics' ChickenBoy robot brings smart analytics to poultry farming
The makers of the AI-based robot for managing large-scale poultry farming are seeking up to €4m in a second round funding as they launch their invention in Europe
The rising Indonesian edtech star wants to help high-school dropouts earn their diploma and learn the relevant skills to find a job – with an innovative solution lauded at this year’s MIT Solve Challenge
Something positive could come out of the Facebook fallout
Users and startups could learn a lot from the Facebook-Cambridge Analytica scandal. For a start, don’t succumb to apathy
Bobobobo: Indonesian luxury at a click
Amid a booming local e-commerce market, this startup carves a niche for itself in upscale trending goods and experiences influenced by Indonesia’s rich traditions
In this shipping container, you can work out and save money
By eliminating the need to pay for an expensive gym membership, ParkBox is good news for gym buffs
Indonesian state enterprises launch e-wallet LinkAja, competing with Go-Pay and OVO
Even with a wider range of services and extensive state backing, LinkAja faces a tough battle
Xiangwushuo’s platform finds a new home for secondhand goods
This WeChat mini program doesn’t yet have a monetization strategy, but has still received over US$110 million in funding in one year
Will China ride into a car-sharing future?
Chinese car-sharing startups face reckoning as more than 500 players crowd into a fast-growing, but young, market
No bank account? In Indonesia, you can still shop online
Indonesian startups are racing to serve the millions of consumers that banks haven’t reached. Here’s a look at some of the leading players, their innovations and how they have redefined the market
Will this one-year-old startup revolutionize traditional industries?
Targeting retail and tourism first, Aibee aims to help traditional businesses keep up with their online counterparts using its all-in-one AI solutions
#WahyooChallenge: From charity to publicity
Inspired by social media trends, the Wahyoo team came up with a way to give back to society, and found their idea going viral
Sorry, we couldn’t find any matches for “Orizon T”.
POPULAR DATABASE
